Drugs for ameliorating retinal function

摘要

The invention is a medicine for improving retinal functions comprising a protein that improves ERG (electroretinogram) recordings. Particularly, a medicine containing tissue-factor-pathway inhibitor-2 or placental protein 5 as the active ingredient can be used for ophthalmic diseases such as glaucoma, occlusion disease of the retinal and choroidal vessels and retinal dysfunctions, as a medicine for improving retinal functions.